Isoprene production using the DXP and MVA pathway
US8507235B2 · kind B2 · utility
7Cited by
17References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 16, 2010 |
| Grant date | Aug 13, 2013 |
| Priority date | — |
| Expiry date | Jul 30, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N15/70
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention provides for methods for producing isoprene from cultured cells using various components of the DXP pathway and MVA pathway, or components associated with the DXP pathway and MVA pathway, iron-sulfur cluster-interacting redox polypeptides, and isoprene synthase. The invention also provides compositions that include these cultured cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.